0001213900-24-016577.txt : 20240226 0001213900-24-016577.hdr.sgml : 20240226 20240223174944 ACCESSION NUMBER: 0001213900-24-016577 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20240223 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240226 DATE AS OF CHANGE: 20240223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Edoc Acquisition Corp. CENTRAL INDEX KEY: 0001824884 STANDARD INDUSTRIAL CLASSIFICATION: FATS & OILS [2070] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39689 FILM NUMBER: 24672907 BUSINESS ADDRESS: STREET 1: 7612 MAIN STREET FISHERS STREET 2: SUITE 200 CITY: VICTOR STATE: NY ZIP: 14564 BUSINESS PHONE: 5856781198 MAIL ADDRESS: STREET 1: 7612 MAIN STREET FISHERS STREET 2: SUITE 200 CITY: VICTOR STATE: NY ZIP: 14564 8-K 1 ea0200659-8k425_edocacq.htm CURRENT REPORT
false 0001824884 00-0000000 0001824884 2024-02-23 2024-02-23 0001824884 ADOC:ClassOrdinaryShares.0001ParValuePerShareMember 2024-02-23 2024-02-23 0001824884 ADOC:RightsExchangeableIntoOnetenthOfOneClassOrdinaryShareMember 2024-02-23 2024-02-23 0001824884 ADOC:WarrantsEachExercisableForOnehalfOfOneClassOrdinaryShareEachWholeWarrantExercisableFor11.50PerShareMember 2024-02-23 2024-02-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): February 23, 2024

 

EDOC Acquisition Corp.

(Exact name of registrant as specified in its charter)

 

Cayman Islands   001-39689   N/A
(State or other jurisdiction
of incorporation)		   (Commission File Number)   (IRS Employer
Identification No.)

 

7612 Main Street Fishers

Suite 200

Victor, NY 14564

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (585) 678-1198

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ☒ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Ordinary Shares, $.0001 par value per share   ADOC   The Nasdaq Stock Market LLC
Rights, exchangeable into one-tenth of one Class A Ordinary Share   ADOCR   The Nasdaq Stock Market LLC
Warrants, each exercisable for one-half of one Class A Ordinary Share, each whole Warrant exercisable for $11.50 per share   ADOCW   The Nasdaq Stock Market LLC

 

 

 

 

 

 

Item 8.01 Other Events.

 

On February 23, 2024, EDOC Acquisition Corp., a special purpose acquisition company incorporated as a Cayman Islands exempted company (“EDOC”) issued a press release announcing that its extraordinary general meeting of its shareholders (the “Meeting”) to approve its proposed initial business combination, which was scheduled for February 26, 2024, has been postponed to 10:00 a.m. Eastern Time, on Wednesday, February 28, 2024. At the Meeting, shareholders of EDOC will be asked to vote on proposals to approve, among other things, its proposed initial business combination with Australian Oilseeds Holdings Limited, a Cayman Islands exempted company (“Pubco”), pursuant to a Business Combination Agreement by and among EDOC, American Physicians LLC, a Delaware limited liability company, AOI Merger Sub, a Cayman Islands exempted company and a wholly-owned subsidiary of Pubco (“Merger Sub”), Australian Oilseeds Investments Pty Ltd., ACN 158 999 949, an Australian proprietary company (“AOI”), Gary Seaton, in his capacity as the representative for the Sellers in accordance with the terms and conditions of the Business Combination Agreement, dated as of December 5, 2022 (as amended on March 31, 2023 and December 7, 2023, and as may be further amended, the “Business Combination Agreement”) and the other parties thereto (the “Proposed Business Combination”). There is no change to the location, the record date, the purpose or any of the proposals to be acted upon at the Meeting.

 

The reason for the postponement is that AOI is engaged in additional negotiations regarding potential financing to occur in connection with the closing of the Proposed Business Combination.

 

As a result of this change, the Meeting will now be held at 10:00 a.m. Eastern Time on Wednesday, February 28, 2024, via the live webcast at https://www.cstproxy.com/edocacquisition/2024. The record date for holders of EDOC’s shareholders for voting in the Meeting remains February 2, 2024 (the “Record Date”).

 

A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

 

Additional Information and Where to Find It

 

In connection with the transactions contemplated by that certain Business Combination Agreement, dated as of December 5, 2022 (as amended on March 31, 2023 and December 7, 2023, and as may be further amended, the “Business Combination Agreement”, and all of the transactions contemplated thereunder, the “Transactions”), by and among EDOC, American Physicians LLC, a Delaware limited liability company, in the capacity as the representative from and after the closing of the transactions contemplated by the Business Combination Agreement for the shareholders of Purchaser and Pubco (other than the Sellers) in accordance with the terms and conditions of the Business Combination Agreement (the “Purchaser Representative”), Pubco, AOI Merger Sub, a Cayman Islands exempted company and a wholly-owned subsidiary of Pubco (“Merger Sub”), AOI, Gary Seaton, in his capacity as the representative for the Sellers in accordance with the terms and conditions of the Business Combination Agreement (the “Seller Representative”) and the other parties thereto, Pubco filed a registration statement on Form F-4 with the U.S. Securities and Exchange Commission (the “SEC”) on September 18, 2023 (as amended or supplemented from time to time, the “Registration Statement”), which includes a proxy statement and a prospectus of EDOC in connection with the Transaction. The Registration Statement was declared effective on February 6, 2024. The definitive proxy statement / prospectus and other relevant documents were mailed to shareholders of EDOC as of February 2, 2024, the record date established for voting on the Transaction. SHAREHOLDERS OF EDOC ARE ADVISED TO READ THE DEFINITIVE PROXY STATEMENT / PROSPECTUS AND ALL OTHER RELEVANT DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC IN CONNECTION WITH THE TRANSACTION, AND ANY AMENDMENTS THERETO, AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. THIS DOCUMENT WILL NOT CONTAIN ALL THE INFORMATION THAT SHOULD BE CONSIDERED CONCERNING THE TRANSACTION. IT IS ALSO NOT INTENDED TO FORM THE BASIS OF ANY INVESTMENT DECISION OR ANY OTHER DECISION IN RESPECT OF THE TRANSACTION. Shareholders may obtain a copy of the Registration Statement, including the proxy statement / prospectus, and other documents filed with the SEC without charge, by directing a request to: Edoc Acquisition Corp. at 7612 Main Street Fishers, Suite 200, Victor, New York 14564. The definitive proxy statement / prospectus included in the Registration Statement can also be obtained, without charge, at the SEC’s website (www.sec.gov).

 

1

 

 

Forward-Looking Statements

 

The information in this report includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “may,” “will,” “expect,” “continue,” “should,” “would,” “anticipate,” “believe,” “seek,” “target,” “predict,” “potential,” “seem,” “future,” “outlook” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, (1) statements regarding estimates and forecasts of financial and performance metrics and projections of market opportunity and market share; (2) references with respect to the anticipated benefits of the proposed Business Combination and the projected future financial performance of EDOC and AOI’s operating companies following the proposed Business Combination; (3) changes in the market for AOI’s products and services and expansion plans and opportunities; (4) AOI’s unit economics; (5) the sources and uses of cash of the proposed Business Combination; (6) the anticipated capitalization and enterprise value of the combined company following the consummation of the proposed Business Combination; (7) the projected technological developments of AOI and its competitors; (8) anticipated short- and long-term customer benefits; (9) current and future potential commercial and customer relationships; (10) the ability to manufacture efficiently at scale; (11) anticipated investments in research and development and the effect of these investments and timing related to commercial product launches; and (12) expectations related to the terms and timing of the proposed Business Combination. These statements are based on various assumptions, whether or not identified in this report, and on the current expectations of AOI’s and EDOC’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of AOI and EDOC. These forward-looking statements are subject to a number of risks and uncertainties, including the occurrence of any event, change or other circumstances that could give rise to the termination of the Business Combination Agreement; the risk that the proposed Business Combination disrupts current plans and operations as a result of the announcement and consummation of the transactions described herein; the inability to recognize the anticipated benefits of the proposed Business Combination; the ability to obtain or maintain the listing of the Pubco’s securities on The Nasdaq Stock Market, following the Business Combination, including having the requisite number of shareholders; costs related to the proposed Business Combination; changes in domestic and foreign business, market, financial, political and legal conditions; risks relating to the uncertainty of the projected financial information with respect to AOI; AOI’s ability to successfully and timely develop, manufacture, sell and expand its technology and products, including implement its growth strategy; AOI’s ability to adequately manage any supply chain risks, including the purchase of a sufficient supply of critical components incorporated into its product offerings; risks relating to AOI’s operations and business, including information technology and cybersecurity risks, failure to adequately forecast supply and demand, loss of key customers and deterioration in relationships between AOI and its employees; AOI’s ability to successfully collaborate with business partners; demand for AOI’s current and future offerings; risks that orders that have been placed for AOI’s products are cancelled or modified; risks related to increased competition; risks relating to potential disruption in the transportation and shipping infrastructure, including trade policies and export controls; risks that AOI is unable to secure or protect its intellectual property; risks of product liability or regulatory lawsuits relating to AOI’s products and services; risks that the post-combination company experiences difficulties managing its growth and expanding operations; the uncertain effects of certain geopolitical developments; the inability of the parties to successfully or timely consummate the proposed Business Combination, including the risk that any required shareholder or regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect the combined company or the expected benefits of the proposed Business Combination; the outcome of any legal proceedings that may be instituted against AOI, EDOC or Pubco or other following announcement of the proposed Business Combination and transactions contemplated thereby; the ability of AOI to execute its business model, including market acceptance of its planned products and services and achieving sufficient production volumes at acceptable quality levels and prices; technological improvements by AOI’s peers and competitors; and those risk factors discussed in documents of Pubco and EDOC filed, or to be filed, with the SEC. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that neither EDOC nor AOI presently know or that EDOC and AOI currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect EDOC’s and AOI’s expectations, plans or forecasts of future events and views as of the date of this report. EDOC and AOI anticipate that subsequent events and developments will cause EDOC’s and AOI’s assessments to change. However, while EDOC and AOI may elect to update these forward-looking statements at some point in the future, EDOC and AOI specifically disclaim any obligation to do so. Readers are referred to the most recent reports filed with the SEC by EDOC. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, and we undertake no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

 

2

 

 

Solicitation Participants

 

EDOC, AOI, the other parties to the Business Combination Agreement, and their respective directors and executive officers, other members of management and employees under SEC rules, may be deemed to be participants in the eventual solicitation of proxies of EDOC’s shareholders in connection with the proposed Business Combination. Prospective investors and securityholders may obtain more detailed information regarding the names and interest in the proposed transaction of such individuals in Pubco’s filings with the SEC, and such information will also be contained in the proxy statement/prospectus when available. You may obtain free copies of these documents from the sources indicated above.

 

No Offer or Solicitation

 

This Current Report on Form 8-K does not constitute (i) a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed Business Combination or (ii) an offer to sell, a solicitation of an offer to buy, or a recommendation to buy any security of AOI, EDOC, or any of their respective affiliates. There shall not be any sale of any securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the laws of such other jurisdiction. No offering of securities shall be made except by means of prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom..

 

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
99.1   Press Release, dated February 23, 2024
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

3

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  EDOC Acquisition Corp.
     
Date: February 23, 2024 By: /s/ Kevin Chen
    Name:  Kevin Chen
    Title: Chief Executive Officer

 

 

4

 

 

 EX-99.1 2 ea0200659ex99-1_edocacq.htm PRESS RELEASE, DATED FEBRUARY 23, 2024

Exhibit 99.1

 

 

 

EDOC ACQUISITION CORP. ANNOUNCES POSTPONEMENT OF

SPECIAL MEETING OF STOCKHOLDERS ON

PROPOSED BUSINESS COMBINATION

 

Victor, NY, Feb. 23, 2024 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (Nasdaq: ADOC) (“EDOC”) announced today that it has postponed its extraordinary general meeting of its shareholders (the “Meeting”) to approve its proposed initial business combination, which was scheduled for February 26, 2024, has been postponed to 10:00 a.m. Eastern Time, on Wednesday, February 28, 2024. At the Meeting, shareholders of EDOC will be asked to vote on proposals to approve, among other things, its proposed initial business combination with Australian Oilseeds Holdings Limited, a Cayman Islands exempted company (“Pubco”), pursuant to a Business Combination Agreement by and among EDOC, American Physicians LLC, a Delaware limited liability company, AOI Merger Sub, a Cayman Islands exempted company and a wholly-owned subsidiary of Pubco (“Merger Sub”), Australian Oilseeds Investments Pty Ltd., ACN 158 999 949, an Australian proprietary company (“AOI”), Gary Seaton, in his capacity as the representative for the Sellers in accordance with the terms and conditions of the Business Combination Agreement, dated as of December 5, 2022 (as amended on March 31, 2023 and December 7, 2023, and as may be further amended, the “Business Combination Agreement”) and the other parties thereto (the “Proposed Business Combination”). There is no change to the location, the record date, the purpose or any of the proposals to be acted upon at the Meeting.

 

The reason for the postponement is that AOI is engaged in additional negotiations regarding potential financing to occur in connection with the closing of the Proposed Business Combination.

  

As a result of this change, the Meeting will now be held at 10:00 a.m. Eastern Time on Wednesday, February 28, 2024, via the live webcast at https://www.cstproxy.com/edocacquisition/2024. The record date for holders of EDOC’s shareholders for voting in the Meeting remains February 2, 2024 (the “Record Date”).

 

If stockholders have any questions or need assistance please contact Advantage Proxy, EDOC’s proxy solicitor, by telephone at (877) 870-8565 or by email at ksmith@advantageproxy.com. EDOC shareholders who hold shares in "street name" (i.e., shareholders whose shares are held of record by a broker, bank, or other nominee) should contact their broker, bank, or nominee to ensure that their shares are voted.

 

About Australian Oilseeds Investments Pty Ltd.

 

Australian Oilseeds Investments Pty Ltd. (the “Company”) is an Australian proprietary company that, directly and indirectly through its subsidiaries, is focused on the manufacture and sale of sustainable oilseeds (e.g., seeds grown primarily for the production of edible oils) and is committed to working with all suppliers in the food supply chain to eliminate chemicals from the production and manufacturing systems to supply quality products to customers globally. The Company engages in the business of processing, manufacture and sale of non-GMO oilseeds and organic and non-organic food-grade oils, for the rapidly growing oilseeds market, through sourcing materials from suppliers focused on reducing the use of chemicals in consumables in order to supply healthier food ingredients, vegetable oils, proteins and other products to customers globally. Over the past 20 years, the Company has grown to the largest cold pressing oil plant in Australia, pressing strictly GMO free conventional and organic oilseeds.

 

 

About EDOC Acquisition Corp.

 

EDOC Acquisition Corp. is a blank check company organized for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company is sponsored by an extensive network of physician entrepreneurs across 30+ medical specialties in leading medical institutions and is led by Kevin Chen, Chief Executive Officer. In November 2020, EDOC consummated an initial public offering of 9 million units, each unit consisting of one Class A ordinary share, one right to receive one-tenth (1/10th) of a Class A ordinary share, upon the consummation by EDOC of its Business Combination and one redeemable warrant, each warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share.

 

 

 

 

ADDITIONAL INFORMATION AND WHERE TO FIND IT

 

This press release relates to the Business Combination between Australian Oilseeds and EDOC. This press release does not constitute an offer to sell or exchange, or the solicitation of an offer to buy or exchange, any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, sale or exchange would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. In connection with the transaction described herein, Australian Oilseeds and EDOC, and/or a successor entity of the transaction has filed or will file relevant materials with the SEC, including a Registration Statement on Form F-4, which was declared effective by the SEC on February 6, 2024, which includes a proxy statement/prospectus of EDOC. The definitive proxy statement/prospectus will be filed with the SEC promptly following the date of this press release and will be sent to all EDOC shareholders. Australian Oilseeds and EDOC, and/or a successor entity of the transaction will also file other documents regarding the proposed transaction with the SEC. Before making any voting or investment decision, investors and security holders of EDOC are urged to read the Registration Statement, the proxy statement/prospectus and all other relevant documents filed or that will be filed with the SEC in connection with the proposed transaction as they become available because they will contain important information about the proposed transaction.

 

Investors and security holders will be able to obtain free copies of the Registration Statement, the proxy statement/prospectus and all other relevant documents filed or that will be filed with the SEC by Australian Oilseeds and EDOC, or any successor entity of the transaction through the website maintained by the SEC at www.sec.gov.

 

The documents filed or that will be filed by EDOC with the SEC also may be obtained free of charge upon written request to EDOC Acquisition Corp., 7612 Main Street Fishers, Suite 200, Victor, NY 14564 or via email to EDOC’s chief executive officer, Kevin Chen at kevin.chen@edocmed.net.

 

The documents filed or that will be filed by Australian Oilseeds with the SEC may be obtained free of charge upon written request to SEC at www.sec.gov or by directing a request to Australian Oilseeds, 126 – 142 Cowcumbla Street, Cootamundra, Australia or via email to Australian Oilseeds’ Chief Financial Officer, Bob Wu at bob@energreennutrition.com.au.

 

Participants in the Solicitation

 

Australian Oilseeds, EDOC and certain of their respective directors, executive officers and other members of management and employees may, under SEC rules, be deemed to be participants in the solicitation of proxies from EDOC’s shareholders in connection with the proposed transaction. Additional information regarding the identity of all potential participants in the solicitation of proxies to EDOC’s shareholders in connection with the Business Combination and other matters to be voted upon at EDOC’s shareholder meeting, and their direct and indirect interests, by security holdings or otherwise, is set forth in EDOC’s proxy statement/prospectus. Investors may obtain such information by reading such proxy statement/prospectus.

 

Non-Solicitation

 

This press release is for informational purposes only and relates to the proposed Business Combination between Australian Oilseeds and EDOC and is not intended and does not constitute a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the potential transaction and shall not constitute an offer to sell or a solicitation of an offer or invitation for the sale or purchase of the securities, assets or the business of EDOC or Australian Oilseeds, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be deemed to be made except by means of a prospectus meeting the requirements of the Securities Act of 1933, as amended.

 

2

 

 

Cautionary Statement Regarding Forward-Looking Statements

 

The information in this press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “may,” “will,” “expect,” “continue,” “should,” “would,” “anticipate,” “believe,” “seek,” “target,” “predict,” “potential,” “seem,” “future,” “outlook” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, (1) statements regarding estimates and forecasts of financial and performance metrics and projections of market opportunity and market share; (2) references with respect to the anticipated benefits of the proposed Business Combination and the related financing transactions and the projected future financial performance of Pubco’s operating companies following the proposed Business Combination and related financing transactions; (3) changes in the market for Pubco’s products and services and expansion plans and opportunities; (4) Pubco’s unit economics; (5) the sources and uses of cash of the proposed Business Combination and the related financing transactions; (6) the anticipated capitalization and enterprise value of Pubco’s following the consummation of the proposed Business Combination and related financing transactions; (7) the projected technological developments of Pubco and its competitors; (8) anticipated short- and long-term customer benefits; (9) current and future potential commercial and customer relationships; (10) the ability to manufacture efficiently at scale; (11) anticipated investments in research and development and the effect of these investments and timing related to commercial product launches; and (12) expectations related to the terms and timing of the proposed Business Combination and the related financing transactions. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of Pubco’s and EDOC’s management and are not predictions of actual performance.

 

These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Pubco, the Company and EDOC. These forward-looking statements are subject to a number of risks and uncertainties, including the occurrence of any event, change or other circumstances that could give rise to the termination of the Business Combination Agreement or the related financing transactions; the risk that the Business Combination or the PIPE disrupts current plans and operations as a result of the announcement and consummation of the transactions described herein; the inability to recognize the anticipated benefits of the Business Combination or the related financing transactions; the ability to obtain or maintain the listing of Pubco’s securities on The Nasdaq Global Market, following the Business Combination, including having the requisite number of shareholders; costs related to the Business Combination and the related financing transactions; changes in domestic and foreign business, market, financial, political and legal conditions; risks relating to the uncertainty of certain projected financial information; the Company’s ability to successfully and timely develop, manufacture, sell and expand its technology and products, including implement its growth strategy; the Company’s ability to adequately manage any supply chain risks, including the purchase of a sufficient supply of critical components incorporated into its product offerings; risks relating to the Company’s operations and business, including information technology and cybersecurity risks, failure to adequately forecast supply and demand, loss of key customers and deterioration in relationships between the Company and its employees; the Company’s ability to successfully collaborate with business partners; demand for the Company’s current and future offerings; risks that orders that have been placed for the Company’s products are cancelled or modified; risks related to increased competition; risks relating to potential disruption in the transportation and shipping infrastructure, including trade policies and export controls; risks that the Company is unable to secure or protect its intellectual property; risks of product liability or regulatory lawsuits relating to the Company’s products and services; risks that the post-combination company experiences difficulties managing its growth and expanding operations; the uncertain effects of the COVID-19 pandemic and certain geopolitical developments; the inability of the parties to successfully or timely consummate the proposed Business Combination or the related financing transactions, including the risk that any required shareholder or regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect the combined company or the expected benefits of the proposed Business Combination or the related financing transactions; the outcome of any legal proceedings that may be instituted against the Company, EDOC or Pubco or other in connection with the proposed Business Combination or related financing transactions; the ability of the Company to execute its business model, including market acceptance of its planned products and services and achieving sufficient production volumes at acceptable quality levels and prices; technological improvements by the Company’s peers and competitors; and those risk factors discussed in documents of Pubco and EDOC filed, or to be filed, with the SEC. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements.

 

There may be additional risks that Pubco, EDOC or the Company presently know or that Pubco, EDOC or the Company currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect EDOC’s, Pubco’s and the Company’s expectations, plans or forecasts of future events and views as of the date of this press release. EDOC, Pubco and the Company anticipate that subsequent events and developments will cause EDOC’s, Pubco’s and the Company’s assessments to change. However, while EDOC, Pubco and the Company may elect to update these forward-looking statements at some point in the future, EDOC, Pubco and the Company specifically disclaim any obligation to do so. Readers are referred to the most recent reports filed with the SEC by EDOC. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, and we undertake no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

 

EDOC Acquisition Corp.

7612 Main Street Fishers, Suite 200

Victor, NY 14564

Attn: Kevin Chen, CEO

Tel: (585) 678-1198

 

3

 

 

 GRAPHIC 3 ex99-1_001.jpg GRAPHIC begin 644 ex99-1_001.jpg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adoc-20240223.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 5 adoc-20240223_def.xml XBRL DEFINITION FILE EX-101.LAB 6 adoc-20240223_lab.xml XBRL LABEL FILE Class of Stock [Axis] Class A Ordinary Shares, $.0001 par value per share Rights, exchangeable into one-tenth of one Class A Ordinary Share Warrants, each exercisable for one-half of one Class A Ordinary Share, each whole Warrant exercisable for $11.50 per share Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 7 adoc-20240223_pre.xml XBRL PRESENTATION FILE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover
Feb. 23, 2024
Document Type 8-K
Amendment Flag false
Document Period End Date Feb. 23, 2024
Entity File Number 001-39689
Entity Registrant Name EDOC Acquisition Corp.
Entity Central Index Key 0001824884
Entity Tax Identification Number 00-0000000
Entity Incorporation, State or Country Code E9
Entity Address, Address Line One 7612 Main Street Fishers
Entity Address, Address Line Two Suite 200
Entity Address, City or Town Victor
Entity Address, State or Province NY
Entity Address, Postal Zip Code 14564
City Area Code 585
Local Phone Number 678-1198
Written Communications true
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Class A Ordinary Shares, $.0001 par value per share  
Title of 12(b) Security Class A Ordinary Shares, $.0001 par value per share
Trading Symbol ADOC
Security Exchange Name NASDAQ
Rights, exchangeable into one-tenth of one Class A Ordinary Share  
Title of 12(b) Security Rights, exchangeable into one-tenth of one Class A Ordinary Share
Trading Symbol ADOCR
Security Exchange Name NASDAQ
Warrants, each exercisable for one-half of one Class A Ordinary Share, each whole Warrant exercisable for $11.50 per share  
Title of 12(b) Security Warrants, each exercisable for one-half of one Class A Ordinary Share, each whole Warrant exercisable for $11.50 per share
Trading Symbol ADOCW
Security Exchange Name NASDAQ
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 4 24 1 false 3 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://edocmed.net/role/Cover Cover Cover 1 false false All Reports Book All Reports adoc-20240223.xsd adoc-20240223_def.xml adoc-20240223_lab.xml adoc-20240223_pre.xml ea0200659-8k425_edocacq.htm http://xbrl.sec.gov/dei/2023 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ea0200659-8k425_edocacq.htm": { "nsprefix": "ADOC", "nsuri": "http://edocmed.net/20240223", "dts": { "schema": { "local": [ "adoc-20240223.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "adoc-20240223_def.xml" ] }, "labelLink": { "local": [ "adoc-20240223_lab.xml" ] }, "presentationLink": { "local": [ "adoc-20240223_pre.xml" ] }, "inline": { "local": [ "ea0200659-8k425_edocacq.htm" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 3, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 4, "entityCount": 1, "segmentCount": 3, "elementCount": 66, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 30 }, "report": { "R1": { "role": "http://edocmed.net/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-02-23", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea0200659-8k425_edocacq.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-02-23", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea0200659-8k425_edocacq.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://edocmed.net/role/Cover" ], "auth_ref": [] }, "ADOC_ClassOrdinaryShares.0001ParValuePerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://edocmed.net/20240223", "localname": "ClassOrdinaryShares.0001ParValuePerShareMember", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class A Ordinary Shares, $.0001 par value per share" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "ADOC_RightsExchangeableIntoOnetenthOfOneClassOrdinaryShareMember": { "xbrltype": "domainItemType", "nsuri": "http://edocmed.net/20240223", "localname": "RightsExchangeableIntoOnetenthOfOneClassOrdinaryShareMember", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Rights, exchangeable into one-tenth of one Class A Ordinary Share" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ADOC_WarrantsEachExercisableForOnehalfOfOneClassOrdinaryShareEachWholeWarrantExercisableFor11.50PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://edocmed.net/20240223", "localname": "WarrantsEachExercisableForOnehalfOfOneClassOrdinaryShareEachWholeWarrantExercisableFor11.50PerShareMember", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Warrants, each exercisable for one-half of one Class A Ordinary Share, each whole Warrant exercisable for $11.50 per share" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://edocmed.net/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 17 0001213900-24-016577-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-24-016577-xbrl.zip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end XML 18 ea0200659-8k425_edocacq_htm.xml IDEA: XBRL DOCUMENT 0001824884 2024-02-23 2024-02-23 0001824884 ADOC:ClassOrdinaryShares.0001ParValuePerShareMember 2024-02-23 2024-02-23 0001824884 ADOC:RightsExchangeableIntoOnetenthOfOneClassOrdinaryShareMember 2024-02-23 2024-02-23 0001824884 ADOC:WarrantsEachExercisableForOnehalfOfOneClassOrdinaryShareEachWholeWarrantExercisableFor11.50PerShareMember 2024-02-23 2024-02-23 iso4217:USD shares iso4217:USD shares false 0001824884 00-0000000 8-K 2024-02-23 EDOC Acquisition Corp. E9 001-39689 7612 Main Street Fishers Suite 200 Victor NY 14564 585 678-1198 true false false false true false Class A Ordinary Shares, $.0001 par value per share ADOC NASDAQ Rights, exchangeable into one-tenth of one Class A Ordinary Share ADOCR NASDAQ Warrants, each exercisable for one-half of one Class A Ordinary Share, each whole Warrant exercisable for $11.50 per share ADOCW NASDAQ